Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

AstraZeneca36 enrolled

Overview

The study aims to evaluate if a GERD treatment programme, in accordance with current regional recommendations, in a company health care setting, has an impact on health related quality of life (HRQoL), symptoms, and productivity in GERD patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

GERD

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Female and/or male aged \> 18 years * Diagnosis of GERD confirmed * Prescription of GERD treatment or already receiving GERD treatment Exclusion Criteria: * Any symptom suggesting a need for further investigation * Previous participation in the present study * Current participation in a clinical study or participation in a clinical study during the last 30 days

Locations (1)

Research Site

Hälsocenter, Södertälje, Sweden

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.